Signal transduction and actin in the regulation of G1-phase progression

Critical Reviews in Eukaryotic Gene Expression

Volumn 15, Issue 3, 2005, Pages 255-275

  Boonstra, Johannes ^a   Moes, Maarten J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Actin binding proteins; Cyclins; Extracellular matrix; FOXO transcription factors; Growth factors; Ongoing cell cycle

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STRUCTURAL PROTEIN; TRANSCRIPTION FACTOR FOXO; CELL CYCLE PROTEIN; GROWTH FACTOR RECEPTOR; INTEGRIN;

APOPTOSIS; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SPREADING; CYTOKINESIS; EXTRACELLULAR MATRIX; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHYSIOLOGY; STRESS FIBER;

MAMMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ANIMALS; CELL CYCLE PROTEINS; G1 PHASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTEGRINS; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; STRESS FIBERS;

EID: 33644891379     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/critreveukargeneexpr.v15.i3.70     Document Type: Review

References (174)

1. Boonstra J. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
2. 1-phase of the on-going cell cycle. J Cell Biochem. 2003;90:244-52.
3. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316-23.
4. Massagué J. G1 cell-cycle control and cancer. Nature. 2004;432:298-306.
5. Coleman ML, Marshall CJ, Olson MF. Ras and Rho GTPases in G1-phase-cell-cycle regulation. Nature Rev Mol Cell Biol. 2004;5:355-66.
6. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173-206.
7. Pawson T. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell. 2004;116:191-203.
8. Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem. 2002;277:11617-20.
9. Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci. 2002;59:126-42.
10. Bird RC. Role of cyclins and cyclin-dependent kinases in G1 phase progression. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
11. Tyner AL, Gartel AL. Roles of cyclin kinase inhibitors in G1 phase progression. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
12. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1 phase progression. Genes Dev. 1999;13:1501-12.
13. Vidal A, Koff A. Cell cycle inhibitors: three families united by a common cause. Gene. 2000;247:1-15.
14. Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995;20:187-90.
15. 1-to-S phase transition. Mol Cell Biol. 1995;15:2612-24.
16. Fotedar R, Fotedar A. Cell cycle control of DNA replication. Prog Cell Cycle Res. 1995;1:73-89.
17. Murray A. Cyclin ubiquitination: the destructive end of mitosis. Cell. 1995;81:149-52.
18. Koepp DM, Harper JW, Elledge SJ. How the cyclins became a cyclin: regulated proteolysis in the cell cycle. Cell. 1999;97:431-4.
19. King RW, Deshaies RJ, Peters JM, Kirschner MW. How proteolysis drives the cell cycle. Science. 1996;274:1652-9.
20. Schafer KA. The cell cycle: a review. Vet Pathol. 1998;35:461-78.
21. Yee AS, Wang JYJ. Role of RB/E2F in G1 phase progression. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences. 2003.
22. 1/S-regulatory genes. Mol Cell Biol. 1995;15:4215-24.
23. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-31.
24. Cinti C, Trimarchi C, Giordano A. G1 phase progression and apoptosis. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
25. Graves JD, Krebs EG. Protein phosphorylation and signal transduction. Pharmacol Ther. 1999;82:111-21.
26. Leof EB. Growth factor receptor signaling: location, location, location. Trends Cell Biol. 2000;10:343-8.
27. Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Pharmacol Toxicol. 2002;42:283-323.
28. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol. 2001;189:1-13.
29. Hulleman E, Boonstra J. Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci. 2001;58:80-93.
30. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for src family kinases. Mol Cell Biol. 1995;15:954-63.
31. Howe A, Aplin AE, Alahar SK, Juliano RL. Integrin signaling and growth control. Curr Opin Cell Biol. 1998;10:220-31.
32. Hanks SK, Polte TR. Signaling through focal adhesion kinase. Bioessays. 1997;19:137-45.
33. Parsons JT. Integrin-mediated signaling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol. 1996;8:146-52.
34. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ. Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem. 1992;267:24796-804.
35. Chuang C-F, Ng S-Y. Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 1994;346:229-34.
36. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 1995;14:951-62.
37. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996;8:205-15.
38. Leinweber BD, Leavis PC, Grabarek Z, Wang C-LA, Morgan KC. Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem J. 1999;344:117-23.
39. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993;72:269-78.
40. Zúñiga A, Torres J, Úbeda J, Pulido R. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the protoplasm. J Biol Chem. 1999;274:21900-7.
41. 2 to variable degrees. J Biol Chem. 2001;276:28976-83.
42. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouysségur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 1999;18:664-74.
43. MAPK and negatively by the p38 HOGMAPK pathway. J Biol Chem. 1996;271:20608-16.
44. Weber JD, Raben DM, Phillips PJ, Baldassare J. Sustained activation of extracellular-regulated-kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J. 1997;326:61-8.
45. Jones SM, Kazlauskas A. Progression from G0 through G1 and into S on two waves of growth factor-driven signaling. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
46. MAPK during the ongoing cell cycle. J Cell Physiol. 1999;180:325-33.
47. mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993;90:8319-23.
48. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouysségur J. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene. 1995;10:1895-904.
49. Sauane M, Correa L, Rogers F, Krasnapolski M, Barraclough R, Rudland PS, Jiménez de Asúa L. Prostaglandin F(2alpha) (PGF(2alpha)) induces cyclin D1 expression and DNA synthesis via early signaling mechanisms in Swiss mouse 3T3 cells. Biochem Biophys Res Comm. 2000;270:11-6.
50. Kim IK, Lee JH, Sohn HW, Kim HS, Kim SH. Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells. FEBS Lett. 1993;321:209-14.
51. 2 activity during the ongoing cell cycle. J Cell Physiol. 2001;188:321-8.
52. 2 and lipoxygenase are involved in cell cycle progression in neuroblastoma cells. Cell Mol Life Sci. 2002;59:181-8.
53. 2 in cell cycle progression. Prog Cell Cycle Res. 2003;5:181-90.
54. Tibbles LA, Woodgett JR. The stress-activated protein kinase pathways. Cell Mol Life Sci. 1999;55:1230-54.
55. Ono K, Han J. The p38 signal transduction pathway, activation and function. Cell Signal. 2000;12:1-13.
56. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J. 2000;346:561-76.
57. Duronio V, Scheid MP, Ettinger S. Downstream signaling events regulated by phosphatidylinositol 3-kinase activity. Cell Signal. 1998;10:233-9.
58. Leslie NR, Downes CP. PTEN: the down side of PI 3-kinase signalling. Cell Signal. 2002;14:285-95.
59. Van Opstal A, Bijvelt JJM, Margadant C, Boonstra J. Role of signal transduction and actin in G1 phase progression. Adv Enzyme Regulat. 2005;45. In press.
60. Comoglio PM, Boccaccio C, Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol. 2003;15:565-71.
61. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol. 2992;4:E83-90.
62. Schwarz MA, Baron V. Interactions between mitogenic stimuli, or a thousand and one connections. Curr Opin Cell Biol. 1999;11:197-202.
63. Schwarz MA, Ginsberg MH. Networks and crosstalk: integrin signaling spreads. Nat Cell Biol. 2002;4:E65-8.
64. Klemke RL, Yebra M, Bayna EM, Cheresh DA. Receptor tyrosine kinase signaling required for integrin αVβ5-directed cell motility but not adhesion on vitronectin. J Cell Biol. 1994;127:859-66.
65. Mainiero F, Pepe A, Yeon M, Ren Y, Giancotti FG. The intracellular functions of α6β4 integrin are regulated by EGF. J Cell Biol. 1996;134:241-53.
66. Trusolino L, Serini G, Cecchini G, Besati C, Ambesi-Impiombato FS, Marchisio PC, De Filippi R. Growth factor-dependent activation of αVβ3 integrin in normal epithelial cells: implications for tumor invasion. J Cell Biol. 1998;142:1145-56.
67. Hulleman E, Bijvelt JJM, Verkleij AJ, Verrips CT, Boonstra J. Integrin signaling at the M/G1 transition induces expression of cyclin E. Exp Cell Res. 1999;253:422-31.
68. 1 phase cell cycle progression. Curr Opin Genet Dev. 2001;11:48-53.
69. Danilkovitch-Miagkova A, Angeloni D, Skeel A, Donley S, Lerman M, Leonard EJ. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src. J Biol Chem. 2000;275:14783-6.
70. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G, Defilippi P. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 1998;17:6622-32.
71. Schneller M, Vuori K, Ruoslahti E. αVβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J. 1997;16:5600-7.
72. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of αVβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 1999;18:882-92.
73. Sundberg C, Rubin K. Stimulation of β1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGFβ-receptors. J Cell Biol. 1996;132:741-52.
74. Wang R, Kobayashi R, Bishop JM. Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. Proc Natl Acad Sci U S A. 1996;93:8425-30.
75. Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol Cell Biol. 2004;24:8586-99.
76. Juliano RL. Regulation of signaling and the cell cycle by cell interactions with the extracellular matrix. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
77. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2000;2:249-56.
78. Cabodi S, Moro L, Bergatto E, Boeri Erba E, Di Stefano P, Turco E, Tarone G, Defilippi P. Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses. Biochem Soc Trans. 2004;32:438-42.
79. Lin T, Chen Q, Howe A, Juliano R. Cell anchorage permits efficient signal transduction between Ras and its down-stream kinases. J Biol Chem. 1997;272:8849-52.
80. Renshaw M, Ren X-D, Schwarz M. Growth factor activation of MAP kinase requires cell adhesion. EMBO J. 1997;16:5592-9.
81. Muñoz-Alonso MJ, León J. G1 phase control and cell differentiation. In: Boonstra J, editor. G1 phase progression. New York: Kluwer Academic/Plenum Publishers, Landes Biosciences; 2003.
82. Hulleman E, Bijvelt JJM, Verkleij AJ, Verrips CT, Boonstra J. Identification of a restriction point at the M/G1 transition in CHO cells. Cell Mol Life Sci. 2004;61:600-9.
83. Burgering MT, Kops GJPL. Cell cycle and death control: long live forkheads. Trends Biochem Sci. 2002;27:352-60.
84. kip1. Nature. 2000;404:782-7.
85. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 1999;96:857-68.
86. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, Coffer PJ. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol. 2002;156:531-42.
87. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL, Lasky LA. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem. 2002;277:14255-65.
88. Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol. 2001;21:3534-46.
89. Dos Remedios CG, Chhabra D, Kekeic M, Dedova I, Tsubakihara M, Berry D, Nosworthy N. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev. 2003;83:433-73.
90. Dominguez R. Actin-binding proteins - a unifying hypothesis. Trends Biochem Soc. 2004;29:572-8.
91. Sellers JR. Myosins, a diverse superfamily. Biochim Biophys Acta. 2000;1496:3-22.
92. McGough AM, Staiger CJ, Min JK, Simonetti KD. The gelsolin family of actin regulatory proteins: modular structures, versatile functions. FEBS Lett. 2003;552:75-81.
93. Gimona M, Djinovic-Carugo K, Kranewitter WJ, Winder SJ. Functional plasticity of CH domains. FEBS Lett. 2002;513:98-106.
94. Lappalainen P, Kessels MM, Cope MJ, Drubin DG. The ADF homology (ADF-H) domain: a highly exploited actin-binding module. Mol Biol Cell. 1998;9:1951-9.
95. Paunola E, Mattila PK, Lappalainen P. WH2 domain: a small versatile adapter for actin monomers. FEBS Lett. 2002;513:92-7.
96. Robinson DN, Spudich JA. Towards a molecular understanding of cytokinesis. Trends Cell Biol. 2000;10:228-37.
97. Glotzer M. The molecular requirements for cytokinesis. Science. 2005;307:1735-9.
98. Hirano A, Kurimura T. Virally transformed cells and cytochalasin B. I. The effect of cytochalasin B on cytokinesis, karyokinesis and DNA synthesis in cells. Exp Cell Res 1974;89:111-20.
99. Uetake Y, Sluder G. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a "tetraploidy checkpoint." J Cell Biol. 2004;165:609-15.
100. Aplin AE, Juliano RL. Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J Cell Sci. 1999;112:695-706.
101. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behaviour. Biochim Biophys Acta. 2004;1692:103-19.
102. Damsky CH, Ilic D. Integrin signaling: it's where the action is. Curr Opin Cell Biol. 2002;14:594-602.
103. DeMali KA, Wennerberg K, Burridge K. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol. 2003;15:572-82.
104. Aspenstrom P. Effectors for the Rho GTPases. Curr Opin Cell Biol. 1999;11:95-102.
105. Burridge K, Wennerberg K. Rho and Rac take center stage. Cell. 2004;116:167-79.
106. Papayannopoulos V, Co C, Prehoda KE, Snapper S, Taunton J, Lim WA. A polybasic motif allows N-WASP to act as a sensor of PIP(2) density. Mol Cell. 2005;17:181-91.
107. Zebda N, Bernard O, Bailly M, Welti S, Lawrence DS, Condeelis JS. Phosphorylation of ADF/cofilin abolishes EGF-induced actin nudeation at the leading edge and subsequent lamellipod extension. J Cell Biol. 2000;151:1119-28.
108. Chinkers M, McKanna JA, Cohen S. Rapid induction of morphological changes in human carcinoma A431 cells by epidermal growth factor. J Cell Biol 1979;83:260-5.
109. Boonstra J, Mummery CL, Feyen A, de Hoog WJ, van der Saag PT, de Laat SW. Epidermal growth factor receptor expression during morphological differentiation of pheochromocytoma cells, induced by nerve growth factor or dibutyryl cyclic AMP. J Cell Physiol 1987;131:409-17.
110. Rijken PJ, Hage WJ, van Bergen en Henegouwen PMP, Verkleij AJ, Boonstra J. Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J Cell Sci. 1991;100:491-9.
111. Rijken PJ, van Hal GJ, van der Heyden MAG, Verkleij AJ, Boonstra J. Actin polymerization is required for negative feedback regulation of epidermal growth factor-induced signal transduction. Exp Cell Res. 1998;243:254-62.
112. Landreth GE, Williams LK, Rieser GD. Association of epidermal growth factor receptor kinase with the detergent insoluble cytoskeleton of A431 cells. J Cell Biol 1985;101:1341-50.
113. Wiegant FAC, Blok FJ, Defize LHK, Linnemans WAM, Verkleij AJ, Boonstra J. Epidermal growth factor receptors associated to cytoskeletal elements of epidermoid carcinoma (A431) cells. J Cell Biol 1986;103:87-94.
114. Roy LM, Gittinger CK, Landreth GE. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells. J Cell Physiol 1989;140:295-304.
115. den Hartigh JC, van Bergen en Henegouwen PMP, Verkleij AJ, Boonstra J. The EGF receptor is an actin-binding protein. J Cell Biol. 1992;119:349-55.
116. Payrastre B, van Bergen en Henegouwen PMP, Breton M, den Hartigh JC, Plantavid M, Verkleij AJ, Boonstra J. Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor. J Cell Biol. 1991;115:121-8.
117. Diakonova M, Payrastre B, van Velzen AG, Hage WJ, van Bergen en Henegouwen PMP, Boonstra J, Cremers AFM, Humbel BM. Epidermal growth factor induces rapid and transient association of phospholipase C-γ1 with EGF-receptor and filamentous actin at membrane ruffles of A431 cells. J Cell Sci. 1995;108:2499-509.
118. c-src substrate. Oncogene. 1992;7:2429-38.
119. Bedrin MS, Abolafia CM, Thompson JF. Cytoskeletal association of epidermal growth factor receptor and associated signaling proteins is regulated by cell density in IEC-6 intestinal cells. J Cell Physiol. 1997;172:126-36.
120. Cenni V, Sirri A, Riccio M, Lattanzi G, Santi S, de Pol A, Maraldi NM, Marmiroli S. Targeting of the Akt/PKB kinase to the actin skeleton. Cell Mol Life Sci. 2003;60:2710-20.
121. Janmey PA. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev. 1998;78:763-81.
122. Fincham VJ, James M, Frame MC, Winder SJ. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 2000;19:2911-23.
123. Besson A, Davy A, Robbins SM, Yong VW. Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene. 2001;20:7398-407.
124. Shono T, Kanetake H, Kanda S. The role of mitogen-activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells. Exp Cell Res. 2001;264:275-83.
125. Hauck CR, Hsia DA, Schlaepfer DD. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem. 2000;275:41092-9.
126. Glading A, Chang P, Lauffenburger DA, Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem. 2000;275:2390-8.
127. Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. Epidermal growth factor activates m-calpain (Calpain II), a least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol. 2004;24:2499-512.
128. Cuevas BD, Abell AN, Witowsky JA, Yujiri T, Johnson NL, Kesavan K, Ware M, Jones PL, Weed SA, DeBiasi RL, Oka Y, Tyler KL, Johnson GL. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J. 2003;22:3346-55.
129. Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr Biol. 2003;13:1442-50.
130. Carragher NO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 2004;14:241-9.
131. 3 for fibrinogen. J Biol Chem. 1999;274:25301-7.
132. Hall A. G proteins and small GTPases: distant relatives keep in touch. Science. 1998;280:2074-5.
133. Calderwood DA, Shattil SJ, Ginsberg MH. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J Biol Chem. 2000;275:22607-10.
134. Maness PF, Walsh RC. Dihydrocytochalasin B disorganizes actin cytoarchitecture and inhibits initiation of DNA synthesis in 3T3 cells. Cell 1982;30:253-62.
135. Ohta T, Takasuka T, Ishibashi S, Ide T. Cytochalasin D inhibits the progression from the G0 to S phase at the mid-prereplicative stage in Gc-7 cells stimulated with serum. Cell Struct Funct 1985;10:37-46.
136. Takasuka T, Ishibashi S, Ide T. Expression of cell cycle-dependent genes in serum stimulated cells whose entry into S phase is blocked by cytochalasin D. Biochim Biophys Acta 1987;909:161-4.
137. Iwig M, Czeslick E, Muller A, Gruner M, Spindler M, Glaesser D. Growth regulation by cell shape alteration and organization of the cytoskeleton. Eur J Cell Biol. 1995;67:145-57.
138. Bohmer RM, Scharf E, Assoian RK. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol Biol Cell. 1996;7:101-11.
139. Fasshauer M, Iwig M, Glaesser D. Synthesis of protooncogene proteins and cyclins depends on intact microfilaments. Eur J Cell Biol. 1998;77:188-95.
140. Huang S, Chen CS, Ingber DE. Control of cyclin D1, p27 (Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell. 1998;9:3179-93.
141. Tsakiridis T, Bergman A, Somwar R, Taha C, Aktories K, Cruz TF, Klip A, Downey GP. Actin filaments facilitate insulin activation of the src and collagen homologous/mitogen activated protein kinase pathway leading to DNA synthesis and c-fos expression. J Biol Chem. 1998;273:28322-31.
142. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang L-S. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Exp Cell Res. 2000;259:35-53.
143. Bottazzi MA, Buzzai M, Zhu X, Desdouets C, Brechot C, Assoian RK. Distinct effects of mitogens and the actin cytoskeleton on CREB and pocket protein phosphorylation control the extent and timing of cyclin A promoter activity. Mol Cell Biol. 2001;21:7607-16.
144. Huang S, Ingber DE. A discrete cell cycle checkpoint in late G1 that is cytoskeleton-dependent and MAP kinase (ERK)-independent. Exp Cell Res. 2002;275:255-64.
145. Lohez OD, Reynaud C, Borel F, Andreassen PR, Margolis RL. Arrest of mammalian fibroblasts in G1 in response to actin inhibition is dependent on retinoblastoma pocket proteins but not on p53. J Cell Biol. 2003;161:67-77.
146. Welsh CF, Roovers K, Villanueva J, Liu Y, Schwartz MA, Assoian RK. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol. 2001;3:950-7.
147. Roovers K, Assoian RK. Effects of Rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G1 phase cyclin-dependent kinases. Mol Cell Biol. 2003;23:4283-94.
148. Schulze A, Zerfass-Thome K, Berges J, Middendorp S, Jansen-Durr P, Henglein B. Anchorage-dependent transcription of the cyclin A gene. Mol Cell Biol. 1996;16:4632-8.
149. Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol. 1996;2:391-403.
150. Resnitzky D. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression. Mol Cell Biol. 1997;17:5640-7.
151. Hansen LK, Albrecht JH. Regulation of the hepatocyte cell cycle by type I collagen matrix: role of cyclin D1. J Cell Sci. 1999;112:2971-81.
152. Herman IM, Pollard TD, Wong AJ. Contractile proteins in endothelial cells. Ann N Y Acad Sci 1982;401:50-60.
153. White GE, Gimbrone MA, Fujiwara K. Factors influencing the expression of stress fibers in vascular endothelial cells in situ. J Cell Biol 1983;97:416-24.
154. Wong AJ, Pollard TD, Herman IM. Actin filament stress fibers in vascular endothelial cells in vivo. Science 1983;219:867-9.
155. Friedl P, Bröcker E-B. The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci. 2000;57:41-64.
156. Bettinger BT, Gilbert DM, Amberg DC. Actin up in the nucleus. Nat Rev Mol Cell Biol. 2004;5:410-5.
157. Philimonenko VV, Zhao J, Iben S, Dingova H, Kysela K, Kahle M, Zentgraf H, Hofmann WA, de Lanerolle P, Hozak P, Grummt I. Nuclear actin and myosin I are required for RNA polymerase I transcription. Nat Cell Biol. 2004;12:1165-72.
158. Wada A, Fukuda M, Mishima M, Nishida E. Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein. EMBO J. 1998;17:1635-41.
159. Steven T, Hartmann E, Görlich D. Exportin 6: a novel nuclear export receptor that is specific for profilin-actin complexes. EMBO J. 2003;22:5928-40.
160. Hofmann WA, Stojiljkovic L, Fuchsova B, Vargas GM, Mavrommatis E, Philimonenko V, Kysela K, Goodrich JA, Lessard JL, Hope TJ, Hozak P, de Lanerolle P. Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol. 2004;11:1094-101.
161. Percipalle P, Fomproix N, Kylberg K, Miralles F, Bjorkroth B, Daneholt B, Visa N. An actin-ribonucleoprotein interaction is involved in transcription by RNA polymerase II. Proc Natl Acad Sci U S A. 2003;100:6475-80.
162. Zhu X, Zeng X, Huang B, Hao S. Actin is closely associated with RNA polymerase II and involved in activation of gene transcription. Biochem Biophys Res Commun. 2004;321:623-30.
163. Fomproix N, Percipalle P. An actin-myosin complex on actively transcribing genes. Exp Cell Res. 2004;294:140-8.
164. Hu P, Wu S, Hernandez N. A role for beta-actin in RNA polymerase III transcription. Genes Dev. 2004;18:3010-5.
165. Gedge LJ, Morrison EE, Blair GE, Walker JH. Nuclear actin is partially associated with Cajal bodies in human cells in culture and relocates to the nuclear periphery after infection of cells by adenovirus 5. Exp Cell Res. 2005;303:229-39.
166. Skare P, Kreivi JP, Bergstrom A, Karlsson R. Profilin I colocalizes with speckles and Cajal bodies: a possible role in pre-mRNA splicing. Exp Cell Res. 2003;286:12-21.
167. Gall JG. Cajal bodies: the first 100 years. Ann Rev Cell Develop Biol. 2000;26:273-300.
168. Darzacq X. Cajal body-specific small nuclear RNAs: a novel class of 2′-O-methylation and pseudouridylation guide RNAs. EMBO J. 2002;21:2746-56.
169. Nakayasu H, Ueda K. Small nuclear RNA-protein complex anchors on the actin filaments in bovine lymphocyte nuclear matrix. Cell Struct Funct 1984;9:317-25.
170. Sahlas DJ, Milankov K, Park PC, De Boni U. Distribution of snRNPs, splicing factor SC-35 and actin in interphase nuclei: immunocytochemical evidence for differential distribution during changes in functional states. J Cell Sci. 1993;105:347-57.
171. Boronenkov IV, Loijens JC, Umeda M, Anderson RA. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell. 1998;9:3547-60.
172. Osborne SL, Thomas CL, Gschmeissner S, Schiavo G. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. J Cell Sci. 2001;114:2501-11.
173. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR. Rapid and phosphoinositol-dependent binding of the SWI-SNF-like BAF complex to chromatin after T-lymphocyte receptor signaling. Cell. 1998;95:625-36.
174. Rando OJ, Zhao K, Janmey P, Crabtree GR. Phosphatidylinositol-dependent actin filament binding by the SWI/SNF-like BAF chromatin remodeling complex. Proc Natl Acad Sci U S A. 2002;99:2824-9.